Medical Kits On Board Ahead of FAA Deadline

Horizon Air announced today that it will begin installation of on board defibrillators and upgraded medical kits on its entire fleet of 60 jets and turboprop aircraft and expects to complete the project by summer 2003, several months ahead of the FAA's April 2004 deadline.To get more news about sof ifak, you can visit rusuntacmed.com official website.

All 467 of Horizon's flight attendants will be trained to operate the automated external defibrillators and employ the emergency medical kits to support a heart attack victim after being revived by the defibrillator. The defibrillator selected by Horizon is manufactured by Medtronic Physio-Control of Redmond, Wash. The kit is manufactured by MedAire of Tempe, Ariz., and includes cardiac drugs and airway equipment and contains basic life support equipment for use by non-medical personnel to address cardiac, respiratory and diabetic emergencies.

"Horizon's proactive decision to update its kit well ahead of the deadline makes a strong statement about the airline's commitment to safety," said Joan Sullivan Garrett, president and CEO of MedAire.

Since 1999, Horizon Air has contracted with MedAire to provide a 24-hour link to emergency physicians on the ground in case of inflight medical emergencies.

A burn cream that was distributed in several types of first aid kits, as well as separately, is being recalled because a U.S. Food and Drug Administration analysis found it was contaminated with Bacillus licheniformis and Bacillus sonorensis.

The FDA recall warns that people who use the recalled Easy Care? AfterBurn? Cream 0.9g single-use packets could experience complications like skin infections and that immunocompromised people may experience severe complications like bacteremia, sepsis or peritonitis.Those who have the impacted products are asked to stop using the Easy Care first aid? AfterBurn? Cream .9g single-use packet and discard it.

Those who experienced any health problems as a result of using the product are advised by the FDA to contact their healthcare provider.